Supreme Court's Landmark Decision: Bayer Triumphs in Roundup Litigation

The U.S. Supreme Court ruled in favor of Bayer, overturning a jury verdict that accused the company of failing to warn users about cancer risks linked to its Roundup weedkiller. This decision potentially curtails thousands of existing and future state-court lawsuits claiming the herbicide causes cancer.

The U.S. Supreme Court delivered a major legal victory to Bayer by restricting numerous state lawsuits alleging its Roundup weedkiller causes cancer. This decision overturned a million-dollar jury verdict in favor of a man diagnosed with lymphoma after using the product, citing preemption by federal pesticide law.

With a 7-2 ruling, the justices agreed that the Federal Insecticide, Fungicide, and Rodenticide Act preempts state-level failure-to-warn claims. Despite repeated EPA findings that glyphosate, Roundup's active ingredient, does not cause cancer, plaintiffs insist otherwise. Bayer faced substantial litigation threats, prompting a multimillion-dollar settlement proposal.

Critics, including public health and environmental activists, condemned the court's decision, labeling it a setback for health protection. Conversely, Bayer argues the ruling facilitates regulatory clarity essential for innovation and industrial stability. The high-stakes case brings to light ongoing debates on pesticide safety and corporate accountability.